KOD

Kodiak Sciences (KOD)

About Kodiak Sciences (KOD)

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Details

Daily high

$35.36

Daily low

$33.26

Price at open

$33.98

52 Week High

$47.84

52 Week Low

$3.43

Market cap

2.1B

Dividend yield

0.00%

Volume

630,099

Avg. volume

714,870

P/E ratio

-8.16

Kodiak Sciences News